| abstract |
abstract “primary carboxamides as btk inhibitors” the invention provides compounds of formula (i): their pharmaceutically acceptable salts, prodrugs, biologically active metabolites, stereoisomers and isomers, in which the variables are defined in the specification. the compounds of the invention are useful for treating immunological and oncological conditions. |